Complete List of Publications:
http://profiles.ouhsc.edu/display/1731793
Most Recent 5 Publications:
- Naggie S, Marks KM, Hughes M, Fierer DS, Macbrayne C, Kim A, Hollabaugh K, Roa J, Symonds B, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Chung R. Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C. Clin Infect Dis. 2017 Feb 27;PubMed PMID: 28329053.
- Bedimo R, Kang M, Tebas P, Overton ET, Hollabaugh K, McComsey G, Bhattacharya D, Evans C, Brown TT, Taiwo B. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Res Hum Retroviruses. 2016 Apr;32(4):325-8. PubMed PMID: 26499270; PubMed Central PMCID: PMC4817562.
- Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS. 2015 Jun 19;29(10):1173-82. PubMed PMID: 26035319; NIHMSID: NIHMS712903; PubMed Central PMCID: PMC4535336.
- de Armendi AJ, Butt AL, Shukry M, Cure JA, Hollabaugh K. A randomized, single-blinded, prospective study that compares complications between cuffed and uncuffed nasal endotracheal tubes of different sizes and brands in pediatric patients. J Clin Anesth. 2015 May;27(3):221-5. PubMed PMID: 25516395.
- Kang M, Hollabaugh K, Pham V, Koletar SL, Wu K, Smurzynski M, Aberg JA. Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. J Acquir Immune Defic Syndr. 2014 Jun 01; 66(2):172-80. PMID: 24694927; PMCID: PMC4169110.